The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 18, Issue 4, Pages 393-401
Publisher
Future Medicine Ltd
Online
2017-02-22
DOI
10.2217/pgs-2016-0174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- No evidence of large genetic effects on steroid response in asthma patients
- (2017) Michael Mosteller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review
- (2016) N. Farzan et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment
- (2016) Steve Turner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma
- (2016) David A. Stempel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report
- (2016) Sorrel E. Wolowacz et al. VALUE IN HEALTH
- The Dutch National Program for Respiratory Research
- (2016) Dirkje S Postma et al. Lancet Respiratory Medicine
- Asthma Pharmacogenomics: 2015 Update
- (2015) Joshua S. Davis et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Genome-wide association study of leukotriene modifier response in asthma
- (2015) A Dahlin et al. PHARMACOGENOMICS JOURNAL
- Monitoring strategies in children with asthma: a randomised controlled trial
- (2015) Sandra Voorend-van Bergen et al. THORAX
- Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma
- (2015) Amber Dahlin et al. PLoS One
- Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids
- (2014) Heung-Woo Park et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the pacman cohort
- (2013) Miranda JL Zuurhout et al. PHARMACOGENOMICS
- Genome-wide Association Identifies theTGene as a Novel Asthma Pharmacogenetic Locus
- (2012) Kelan G. Tantisira et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Tailored second-line therapy in asthmatic children with the Arg16genotype
- (2012) Brian J. Lipworth et al. CLINICAL SCIENCE
- Pharmacogenetics of asthma controller treatment
- (2012) E B Mougey et al. PHARMACOGENOMICS JOURNAL
- FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children
- (2011) E. S. Koster et al. ALLERGY
- Genomewide Association betweenGLCCI1and Response to Glucocorticoid Therapy in Asthma
- (2011) Kelan G. Tantisira et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age and Risks of FDA-Approved Long-Acting 2-Adrenergic Receptor Agonists
- (2011) A. W. McMahon et al. PEDIATRICS
- Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
- (2010) Robert F. Lemanske et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol
- (2009) Kaninika Basu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial
- (2009) Michael E Wechsler et al. LANCET
- 5-Lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci
- (2009) Kelan G. Tantisira et al. Pharmacogenetics and Genomics
- Predictors of poor response during asthma therapy differ with definition of outcome
- (2009) Angela J Rogers et al. PHARMACOGENOMICS
- Economic burden of asthma: a systematic review
- (2009) Katayoun Bahadori et al. BMC Pulmonary Medicine
- ALOX5 promoter genotype and response to montelukast in moderate persistent asthma
- (2008) Juan J. Telleria et al. RESPIRATORY MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started